Eric J. Dippel, MD

Original Contribution

Long-Term Outcomes in Treating Left Main Trifurcation Coronary Artery Disease with the Paclitaxel-Eluting Stent

08/01/2008

Eric J. Dippel , MD;

Jon Robken , MD;

Michael Jerin , PhD;

Peter Sharis , MD;

Penny Stoakes , RN;

Jeannette Byrd , RN;

Amber Avila , BSc;

Lauren Gehbauer , BSc;

Leslie Farland ;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Stephanie Brosius ;

Gail A. Shammas , BSN, BS , RN, BSc;

Matthew Winter ;

Lynne Majetic , RN;

Left main (LM) trifurcation coronary stenting is a challenging and complex percutaneous procedure that has been reported in small series and case reports.1–5 Typically, this disease is treated surgically, but with the advent of drug-eluting...

Left main (LM) trifurcation...

08/01/2008

Journal of Invasive Cardiology

OBL Corner

Why I Choose to Have an Office-Based Lab

05/02/2021

Eric J. Dippel , MD;

What does a complex multi-billion cell organism, like a human, and a simple, single-cell organism, like an amoeba, have in common? Both have a primal desire to avoid noxious stimuli. How is this related to having an office-based lab?

What does a complex...

05/02/2021

Vascular Disease Management

Original Contribution

Twelve-Month Results of Percutaneous Endovascular Reconstruction for Chronically Occluded Superficial Femoral Arteries: A Qualit

08/01/2008

Lauren Coyne ;

Jon H. Lemke , PhD, MD;

Eric J. Dippel , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Vickie S. Takes , RT(R), CCRC, RN;

Atherosclerotic peripheral vascular disease (PVD) is an underdiagnosed, undertreated, age-dependent, debilitating condition. Conservative estimates suggest that between 8 and 12 million people in the United States have PVD.1 The incidence of...

Atherosclerotic peripheral...

08/01/2008

Journal of Invasive Cardiology

Original Research

Bivalirudin in Peripheral Vascular Interventions: A Single Center Experience

09/05/2008

Dawn E. McKinney , MA;

Monica Youngblut , RN;

Eric J. Dippel , MD;

Melodee Harris , RN, BSc;

Vickie S. Takes , RT(R), CCRC, RN;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Jon H. Lemke , PhD, MD;

Unfractionated heparin is the current antithrombotic agent utilized during peripheral angioplasty procedures.

Unfractionated heparin is the...

09/05/2008

Vascular Disease Management

Original Contribution

Routine Visualization of the Left Internal Mammary Artery before Bypass Surgery: Is It Necessary?

08/01/2008

Eric J. Dippel , MD;

Pragnesh Patel , MD;

Catherine Harb , BS;

Jon H. Lemke , PhD, MD;

Matthew J. Kapalis , DO, BA, BSc, BS;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

The use of the left internal mammary artery (LIMA) to bypass the left anterior descending artery (LAD) is the “gold standard” of coronary artery revascularization. Studies have shown improved patency1–4 and survival3,5–9 with LIMA use. It...

The use of the left internal...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

In-Hospital Complications of Peripheral Vascular Interventions Using Unfractionated Heparin as the Primary Anticoagulant

08/01/2008

Monica Youngblut , RN;

Melodee Harris , RN, BSc;

Vickie S. Takes , RT(R), CCRC, RN;

Jane Holden , RN;

Jon H. Lemke , PhD, MD;

Matthew J. Kapalis , DO, BA, BSc, BS;

Eric J. Dippel , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Catherine Harb , BS;

Dawn E. McKinney , MA;

Unfractionated heparin is the current antithrombotic of choice in peripheral vascular interventions. Heparin has an unpredictable anticoagulation response, is an indirect thrombin inhibitor, does not inhibit bound thrombin and activates...

Unfractionated heparin is the...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Utilization of GP IIb/IIIa Inhibitors in Peripheral Percutaneous<br />
Interventions: Current Applications and In-Hospital Outcomes<br />

08/01/2008

Eric J. Dippel , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Gail A. Shammas , BSN, BS , RN, BSc;

Michael Jerin , PhD;

Alisha Kumar , BS;

Lynn Kennedy ;

Thrombus is highly prevalent in patients with peripheral arterial disease, particularly those with recent symptoms and occluded or subtotally occluded vessels. In a prospective registry of 17 consecutive patients with recent (< 6 months)...

Thrombus is highly prevalent in...

08/01/2008

Journal of Invasive Cardiology

Bivalirudin in Peripheral Vascular Interventions: A Single Center Experience<br />

08/01/2008

Monica Youngblut , RN;

Eric J. Dippel , MD;

Melodee Harris , RN, BSc;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Vickie S. Takes , RT(R), CCRC, RN;

Jon H. Lemke , PhD, MD;

Dawn E. McKinney , MA;

Unfractionated heparin (UFH) is the current antithrombotic agent utilized during peripheral angioplasty procedures (PTA). UFH has an unpredictable anticoagulation response, is an indirect thrombin inhibitor, does not inhibit bound thrombin...

Unfractionated heparin (UFH) is...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Treatment of Left Main Coronary Trifurcation Lesions with the Paclitaxel Drug-Eluting Stent (Full title below)

07/13/2009

Eric J. Dippel , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Jon Robken , MD;

Gail A. Shammas , BSN, BS , RN, BSc;

Michael Jerin , PhD;

Anup Parikh ;

Katherine Coin ;

Peter Sharis , MD;

Treatment of Left Main Coronary Trifurcation Lesions with the Paclitaxel Drug-Eluting Stent: Mid-Term Outcomes from a Tertiary Medical Center ABSTRACT: Background. Left main trifurcating coronary artery disease (LMTCAD) is a complex and...

Treatment of Left Main Coronary...

07/13/2009

Journal of Invasive Cardiology

Eptifibatide in Peripheral Vascular Interventions: Results of
the Integrilin Reduces Inflammation in Peripheral Vascular Interv

08/01/2008

Vickie S. Takes , RT(R), CCRC, RN;

Jon H. Lemke , PhD, MD;

Matthew J. Kapalis , DO, BA, BSc, BS;

Jon Robken , MD;

H. Lester Kirchner , MD;

Theresa Palabrica , MD;

Eric J. Dippel , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Balloon injury to the vessel wall triggers a reaction of thrombosis, inflammation and neointimal proliferation. The inflammatory process is mediated by a complex interaction between blood cells (platelets and leukocytes), coagulation factors...

Balloon injury to the vessel...

08/01/2008

Journal of Invasive Cardiology